ANRO Operating Cash Flow (Statement)
Alto Neuroscience, Inc. Common Stock · Operating Cash Flow (Statement)
ANRO Operating Cash Flow (Statement)
Latest reported-$68.29Mperiod ending
ANRO TTM Cash from Operations (-$27.95M → -$68.29M)
TTM operating cash flow (statement)
High-resolution chart · PNG
ANRO operating cash flow (statement) history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Operating Cash Flow (Statement) (USD) |
|---|---|
| -68,285,000 | |
| -62,304,000 | |
| -51,769,000 | |
| -53,274,000 | |
| -55,082,000 | |
| -52,997,000 | |
| -47,424,000 | |
| -45,927,000 | |
| -41,966,000 | |
| -36,907,000 | |
| -33,448,000 | |
| -27,945,000 |